Supernus Pharmaceuticals (SUPN) Slid on Disappointing Progress Report on a Key Drug
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Small Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.